Infection by group A streptococci may lead to chronic inflammatory lesions of the myocardium, heart valves, joints, and skin. The pathogenesis of these lesions remains uncertain (1), and several experimental animal models have been used to study chronic inflammation induced by group A streptococci and their extracellular products (2). Cell wall preparations containing only type-specific polysaccharide and peptidoglycan (PPG) 1 have the capacity to induce chronic-recurring granulomatous lesions in the skin of rabbits (3), lesions resembling those of rheumatic fever in the hearts of mice (4) and rabbits (5), and severe polyarthritis in rats (6). Available evidence indicates that PPG induces inflammatory lesions by direct interaction with infiltrating leukocytes, rather than by an immunopathologic mechanism (7). In experimental lesions, PPG becomes associated with macrophages (3), and it appears that these cells lack .the ability to digest the material (5, 8-11). These observations have led us to investigate the effects of PPG on mouse peritoneal macrophages maintained in culture. We have found that PPG, at concentrations which do not appear to be cytotoxic, induces marked morphologic and biochemical changes in these cells. They undergo a three-to fourfold increase in size, and there is a significant elevation in the levels of acid hydrolases and other cellular enzymes. Furthermore, there is a selective release of the hydrolases into the extracellular environment with no detectable loss of cell viability.
Materials and MethodsMaterials.--Bovine pancreatic ribonuclease (type I-A), twice crystallized pancreatic trypsin (type III), phenolphthalein glucuronic acid 0.01 M, pH 7.0; o-nitrophenyl-/3-1)-galactopyranoside, leucine-2-naphthylamide, ¢z-naphthyl acid phosphate and glycogen type II (from